Search NASA⌕ Search

Engineering topics

Wijesooriya, K

Publications and source records attributed to Wijesooriya, K.

SU-F-T-658: Out-Of-Field Dose Comparison for TrueBeam Low Energy Beams for Extended Distances: Measurement Vs Monte Carlo Simulation

Purpose: Patient dose far from the treatment field is comprised of scatter from within the patient, and treatment head leakage. We quantify the treatment head leakage for TrueBeam linear accelerator for 6X and 6X-FFF beams by comparing measurements to Monte Carlo simulations for a variety of jaw sizes and collimator rotations. This work is conceptually similar to that of Kry et al. (Medical Physics 2006; 33: 4405), who considered a Clinac linear accelerator. Methods: Measurements were made using an EXRADIN A101 ion chamber positioned in the patient plane, at distances up to 100 cm from isocenter. Simulations were done using VirtuaLinac, the GEANT4-based Monte Carlo model of the TrueBeam treatment head, and an in-house (U. Virginia) GEANT4-based code. In-house code modelled an ion chamber with build-up, based on a CT scan of the chamber. VirtuaLinac included a detailed model of the treatment head shielding, and was run on the Amazon Web Services cloud to generate spherical phase space files surrounding the treatment head. These phase space files were imported into the in-house code. Results: Initial comparisons between measurements and simulation showed an excess of dose in the in-plane direction, away from the gantry, in the simulations. This was traced to an incomplete model of the shielding—specifically, the component holding the primary collimator was smaller in the model than in the TrueBeam. Modifications were made to VirtuaLinac to more closely match the engineering drawings. In the in-plane direction, the lowest out of field dose was away from gantry (negative abscissa values) at around 60 cm from isocenter, for fields smaller than 10×10 cm2. Out of field dose decreased with decreasing jaw size. Flattening-filter free beam produced out-of-field doses as low as 65% of those with flattened beam. Conclusion: Doses determined from simulation and measurement were in close agreement. Funding support from the Jefferson Trust Foundation.

60 APPLIED LIFE SCIENCES↗

SU-E-T-158: Catching Errors with Trajectory Log Files

Purpose: To present our single institution experience on catching errors with trajectory log file analysis. The reported causes of failures, probability of occurrences (O), severity of effects (S), and the probability of the failures to be undetected (D) could be added to guidelines of FMEA analysis. Methods: From March 2013 to March 2014, 19569 patient treatment fields/arcs were analyzed. This work includes checking all 131 treatment delivery parameters for all patients, all treatment sites and all treatment delivery fractions. TrueBeam trajectory log files for all treatment field types as well as all imaging types were accessed, read in every 20ms, and every control point (total of 37 million parameters) compared to the physician approved plan in the planning system. Results: Couch angle outlier occurrence: N= 327, range = −1.7 −1.2 deg; gantry angle outlier occurrence: N =59, range = 0.09 – 5.61 deg, collimator angle outlier occurrence: N = 13, range = −0.2 – 0.2 deg. VMAT cases have slightly larger variations in mechanical parameters. MLC: 3D single control point fields have a maximum deviation of 0.04 mm, 39 step and shoot IMRT cases have MLC −0.3 – 0.5 mm deviations, all (1286) VMAT cases have −0.9 – 0.7 mm deviations. Two possible serious errors were found: 1) A 4 cm isocenter shift for the PA beam of an AP-PA pair, under-dosing a portion of PTV by 25%. 2) Delivery with MLC leaves abutted behind the jaws as opposed to the midline as planned, leading to a under-dosing of a small volume of the PTV by 25%, by just the boost plan. Due to their error origin, neither of these errors could have been detected by pre-treatment verification. Conclusion: Performing Trajectory Log file analysis could catch typically undetected errors to avoid potentially adverse incidents.

60 APPLIED LIFE SCIENCES↗

SU-F-BRD-05: Dosimetric Comparison of Protocol-Based SBRT Lung Treatment Modalities: Statistically Significant VMAT Advantages Over Fixed- Beam IMRT

Purpose: The purpose of this study is to inter-compare and find statistically significant differences between flattened field fixed-beam (FB) IMRT with flattening-filter free (FFF) volumetric modulated arc therapy (VMAT) for stereotactic body radiation therapy SBRT. Methods: SBRT plans using FB IMRT and FFF VMAT were generated for fifteen SBRT lung patients using 6 MV beams. For each patient, both IMRT and VMAT plans were created for comparison. Plans were generated utilizing RTOG 0915 (peripheral, 10 patients) and RTOG 0813 (medial, 5 patients) lung protocols. Target dose, critical structure dose, and treatment time were compared and tested for statistical significance. Parameters of interest included prescription isodose surface coverage, target dose heterogeneity, high dose spillage (location and volume), low dose spillage (location and volume), lung dose spillage, and critical structure maximum- and volumetric-dose limits. Results: For all criteria, we found equivalent or higher conformality with VMAT plans as well as reduced critical structure doses. Several differences passed a Student's t-test of significance: VMAT reduced the high dose spillage, evaluated with conformality index (CI), by an average of 9.4%±15.1% (p=0.030) compared to IMRT. VMAT plans reduced the lung volume receiving 20 Gy by 16.2%±15.0% (p=0.016) compared with IMRT. For the RTOG 0915 peripheral lesions, the volumes of lung receiving 12.4 Gy and 11.6 Gy were reduced by 27.0%±13.8% and 27.5%±12.6% (for both, p<0.001) in VMAT plans. Of the 26 protocol pass/fail criteria, VMAT plans were able to achieve an average of 0.2±0.7 (p=0.026) more constraints than the IMRT plans. Conclusions: FFF VMAT has dosimetric advantages over fixed beam IMRT for lung SBRT. Significant advantages included increased dose conformity, and reduced organs-at-risk doses. The overall improvements in terms of protocol pass/fail criteria were more modest and will require more patient data to establish difference trends of more statistical significance.

60 APPLIED LIFE SCIENCES↗

MO-C-BRD-01: SBRT I: Overview of Simulation, Planning, and Delivery

SBRT is having a dramatic impact on radiation therapy of early-stage, locally advanced cancers. Treatment planning of SBRT is characterized by precise target volume delineation, highly conformal dose distribution, sharp dose gradient outside the target volume, and meticulous tumor motion management. Stringent dose volume constraints of SBRT require the treatment planning to be highly personalized. Not only the complete patient's medical information (anatomy, tumor size/shape/location/motion, breathing pattern, health status) should be taken into consideration during planning, but also a wide range of factors including imaging techniques (imaging modality, breathing control, immobilization, patient position, etc.), treatment planning techniques (3D-conformal, dynamic conformal arcs, IMRT, VMAT, etc.), image guidance techniques (CBCT, orthogonal X-Ray, fiducial marker tracking, fluoroscopy, etc.), and delivery techniques (FFF, gating, tracking, etc.). In addition, potential pitfalls may exist in SBRT techniques and processes, such as target volume error in 4DCT and image registration error in image guidance. How to manage these affecting factors to achieve optimal, personalized SBRT treatment plans remains a great challenge. In this proposal, we will review technologies, share experiences, and discuss strategies concerning SBRT simulation, planning, and delivery. Learning Objectives: Understand requirements and challenges of SBRT treatment planning Discuss information-driven strategies of developing optimal SBRT plans Discuss practical considerations and potential pitfalls of SBRT treatment planning.

60 APPLIED LIFE SCIENCES↗

SU-E-T-248: Near Real-Time Analysis of Radiation Delivery and Imaging, Accuracy to Ensure Patient Safety

Purpose: To develop and optimize an effective software method for comparing planned to delivered control point machine parameters for all VARIAN TrueBeam treatments so as to permit (1) assessment of a large patient pool throughout their treatment course to quantify treatment technique specific systematic and random uncertainty of observables, (2) quantify the site specific daily imaging shifts required for target alignment, and (3) define tolerance levels for mechanical parameters and imaging parameters based on statistical analysis data gathered, and the dosimetric impact of variations. Methods: Treatment and imaging log files were directly compared to plan parameters for Eclipse and Pinnacle planned treatments via 3D, IMRT, control point, RapidArc, and electrons. Each control point from all beams/arcs (7984) for all fractions (1940) of all patients treated over six months were analyzed. At each control point gantry angle, collimator angle, couch angle, jaw positions, MLC positions, MU were compared. Additionally per-treatment isocenter shifts were calculated. Results were analyzed as a whole in treatment type subsets: IMRT, 3D, RapidArc; and in treatment site subsets: brain, chest/mediastinum, esophagus, H and N, lung, pelvis, prostate. Results: Daily imaging isocenter shifts from initial external tattoo alignment were dependent on the treatment site with < 0.5 cm translational shifts for H and N, Brain, and lung SBRT, while pelvis, esophagus shifts were ∼1 cm. Mechanical delivery parameters were within tolerance levels for all sub-beams. The largest variations were for RapidArc plans: gantry angle 0.11±0.12,collimator angle 0.00±0.00, jaw positions 0.48±0.26, MLC leaf positions 0.66±0.08, MU 0.14±0.34. Conclusion: Per-control point validation reveals deviations between planned and delivered parameters. If used in a near real-time error checking system, patient safety can be improved by equipping the treatment delivery system with additional forcing functions which by-pass human error avenues.

60 APPLIED LIFE SCIENCES↗

The Partonic Structure of the Pion at Large-x

Unlike the proton, whose parton distributions have been extracted using abundant data, the pion has been relatively ignored. The pion, nevertheless, is a crucial part of the current understanding of the nucleon's parton distributions and of the binding of the nucleon into a nucleus. The pion's structure becomes more intriguing when its dual roles as a light quark-antiquark system and as QCD's Goldstone boson are considered. One source of data on the pion's structure is pion-induced Drell-Yan scattering. Two recent re-analyses of such data are discussed here.

72 PHYSICS OF ELEMENTARY PARTICLES AND FIELDS↗